Vetsys Pharmaceutical
Advanced concentrated formulas designed for the North American clinical and commercial standards.
The United States has emerged as one of the most sophisticated markets for Herbal Medicine Extracts. With an increasing shift toward integrative medicine and holistic wellness, the demand for high-purity, standardized botanical extracts has reached unprecedented levels. Modern American consumers are no longer satisfied with raw herbs; they demand bioavailable, scientifically-verified concentrated compounds.
In the industrial sector, the US botanical market is governed by rigorous FDA (Food and Drug Administration) guidelines under the DSHEA framework. This has forced manufacturers to transition from traditional brewing methods to AI-driven, high-precision extraction technologies like Supercritical CO2 and Ultrasonication. As a leading exporter to the US, we understand that "Quality" means more than just purity—it means consistent potency across every batch.
The localized application scenarios in the US range from Functional Foods in California's tech hubs to Pharmaceutical Grade Veterinary Medicines in the Midwest’s vast agricultural belts. Our extracts are specifically processed to meet these diverse logistical and regulatory needs.
1. Dietary Supplements: Standardized powders for encapsulated immunity boosters.
2. Animal Health: High-purity herbal additives for the US poultry and livestock industry, reducing antibiotic reliance.
3. Cosmeceuticals: Botanicals like Chrysanthemum and Lily Bulb extracts for high-end skincare brands in New York and LA.
Established in 2005, Zhengzhou Vetsys Pharmaceutical Co., Ltd. (Vetsys) is a leading manufacturer in the animal pharmaceutical industry with a registered capital of 30 million RMB. The facility includes specialized workshops for producing a wide range of products, including powders & premixes, injections, powder injections, oral solutions, tablets, granules, herbal drug extracts, and disinfectants.
Vetsys operates in compliance with strict Good Manufacturing Practices (GMP) to ensure that all products meet the highest quality standards. Over the years, the company has grown to become one of the top animal pharmaceutical producers in China, achieving annual sales of over USD 20 million in the domestic market by 2015.
Technological Innovation and Research: Vetsys distinguishes itself from competitors by placing a strong emphasis on technological development and continuous innovation. We have established an independent research institute equipped with five specialized laboratories and a team of world-class scientists. This enables us to quickly adapt to market demands and produce cutting-edge solutions for animal health.
Our commitment to research ensures that Vetsys remains at the forefront of the industry, continuously enhancing our product offerings and contributing to advancements in animal healthcare.
Quality is the cornerstone of our operations, and Vetsys has developed a comprehensive quality management system to oversee every aspect of production. We adhere to rigorous GMP standards, ensuring that all products are manufactured under optimal conditions and undergo extensive quality control checks before reaching the market. Vetsys believes that excellence in product quality is essential to long-term growth and sustainability, both for the company and the animal health industry as a whole.
As part of our long-term vision, Vetsys is also committed to sustainability. We continue to invest in green technologies and environmentally friendly practices to minimize the impact of our operations on the environment. Our products are not only designed for efficacy but also to promote the overall well-being of both animals and the environment.
Pure, potent, and compliant with international pharmacopoeia standards.
Navigating the supply chain for Herbal Medicine Extracts in the United States requires a partner who understands both the botanical science and the regulatory hurdles. As a specialized manufacturer, we bridge the gap between traditional wisdom and modern US industrial needs.
Every extract batch exported to the United States undergoes HPLC (High-Performance Liquid Chromatography) testing to ensure the fingerprint of the herb matches the therapeutic profile required. Our 45% Mangiferin Mango Leaf Extract and 10% Salvia Miltiorrhiza are prime examples of precision engineering in plant medicine.
Modern US businesses prioritize sustainability. We utilize eco-friendly extraction methods that minimize carbon footprints, aligning with the "Green Chemistry" trends seen in the Pacific Northwest and New England healthcare sectors.
Given our deep roots in animal pharmaceutical manufacturing, we provide specific extracts like Astragalus Polysaccharides that are optimized for livestock immunity, catering to the growing "Antibiotic-Free" meat production market in the United States.